Eli Lilly Stock: What Investors Should Watch in 2025
GLP-1 treatments such as semaglutide (under the brand names Ozempic and Wegovy) by Novo Nordisk (NYSE:NVO) were likely the hottest medical sector story in 2024. With its offering of tirzepatide (branded as Mounjaro and Zepbound), Eli Lilly (NYSE:LLY) was …